25 June 2026
US prescription drug spending is forecast to exceed $560bn in 2026 as demand for GLP-1 obesity and diabetes treatments continues to rise.
11 November 2025
Examine the ongoing battle over US drug prices and the potential effects of Trump's recent pharma agreements on affordability.
11 November 2025
The landmark obesity drug deal announced by Trump aims to make weight management drugs more affordable for millions of patients.
2 July 2025
29 June 2025
Examine the realities of Australia's crumbling universal healthcare system and how funding problems are affecting patients nationwide.
29 June 2025
Get insights on the Trump drug price executive order and how it may reshape timelines for drug price negotiations.